	US 12,257,121 B2
	Smart composite with antibiofilm, mineralizing, and antiinfection therapeutic effects
Santiago Orrego, Philadelphia, PA (US)
Assigned to Temple University—Of The Commonwealth System of Higher Education
Appl. No. 17/442,357
Filed by Temple University—Of The Commonwealth System of Higher Education, Philadelphia, PA (US)
PCT Filed Mar. 26, 2020, PCT No. PCT/US2020/024951 § 371(c)(1), (2) Date Sep. 23, 2021, PCT Pub. No. WO2020/198468, PCT Pub. Date Oct. 1, 2020.
Claims priority of provisional application 62/823,833, filed on Mar. 26, 2019.
Prior Publication US 2022/0160464 A1, May 26, 2022
Int. Cl. A61C 5/40 (2017.01); A61C 8/00 (2006.01); A61C 8/02 (2006.01); A61K 6/15 (2020.01); A61K 6/20 (2020.01); A61K 6/60 (2020.01); A61L 27/06 (2006.01); A61L 27/30 (2006.01); A61L 27/44 (2006.01); A61L 27/54 (2006.01); B82Y 5/00 (2011.01); B82Y 40/00 (2011.01)

CPC A61C 5/40 (2017.02) [A61C 8/0007 (2013.01); A61C 8/0013 (2013.01); A61K 6/15 (2020.01); A61K 6/20 (2020.01); A61K 6/60 (2020.01); A61L 27/06 (2013.01); A61L 27/306 (2013.01); A61L 27/446 (2013.01); A61L 27/54 (2013.01); A61L 2300/404 (2013.01); A61L 2400/12 (2013.01); A61L 2430/12 (2013.01); B82Y 5/00 (2013.01); B82Y 40/00 (2013.01)]

12 Claims

1. A composite comprising a polymer matrix and piezoelectric material particles, wherein the piezoelectric material particles are dispersed within the polymer matrix at a ratio of the piezoelectric material particles to polymer matrix of at least 1:100, and wherein the piezoelectric material particles are BaTiO₃(BTO), and wherein the amount of the BTO in the composite is about 10%.